Scarica l'app Stockscreener
6.51
4.16%
0.26
Dopo l'orario di chiusura:
6.51
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.25
Aprire:
$6.24
Volume 24 ore:
519.76K
Relative Volume:
1.33
Capitalizzazione di mercato:
$419.72M
Reddito:
-
Utile/perdita netta:
$-45.08M
Rapporto P/E:
-8.9178
EPS:
-0.73
Flusso di cassa netto:
$-33.68M
1 W Prestazione:
+8.14%
1M Prestazione:
+18.15%
6M Prestazione:
+375.18%
1 anno Prestazione:
+208.53%
Intervallo 1D:
$6.10
$6.6688
Intervallo di 1 settimana:
$5.10
$6.6688
Portata 52W:
$0.726
$6.6688
Galectin Therapeutics Inc Stock (GALT) Company Profile
Nome
Galectin Therapeutics Inc
Settore
Industria
Telefono
678-620-3186
Indirizzo
4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA
Confronta GALT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GALT
Galectin Therapeutics Inc
|
6.51 | 402.95M | 0 | -45.08M | -33.68M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-17 | Ripresa | H.C. Wainwright | Buy |
| 2020-08-13 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-13 | Iniziato | B. Riley FBR | Buy |
| 2017-12-07 | Reiterato | H.C. Wainwright | Buy |
| 2017-11-28 | Reiterato | H.C. Wainwright | Buy |
| 2017-10-19 | Iniziato | ROTH Capital | Buy |
| 2017-03-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2016-10-03 | Downgrade | FBR & Co. | Outperform → Mkt Perform |
| 2016-09-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2016-09-28 | Downgrade | ROTH Capital | Buy → Sell |
| 2016-03-28 | Ripresa | H.C. Wainwright | Buy |
| 2015-09-21 | Iniziato | H.C. Wainwright | Buy |
| 2014-08-01 | Downgrade | Aegis Capital | Buy → Hold |
| 2014-07-30 | Reiterato | MLV & Co | Buy |
| 2014-07-29 | Reiterato | MLV & Co | Buy |
| 2014-04-02 | Reiterato | MLV & Co | Buy |
| 2014-02-10 | Reiterato | Aegis Capital | Buy |
| 2014-01-09 | Reiterato | Aegis Capital | Buy |
| 2013-12-03 | Iniziato | MLV & Co | Buy |
| 2013-08-19 | Reiterato | Aegis Capital | Buy |
Mostra tutto
Galectin Therapeutics Inc Borsa (GALT) Ultime notizie
Fundamentals Check: Will Galectin Therapeutics Inc stock benefit from AI adoptionDay Trade & Real-Time Market Sentiment Alerts - moha.gov.vn
Market Pulse: Will Galectin Therapeutics Inc stock benefit from AI adoptionJuly 2025 Sentiment & Daily Stock Trend Watchlist - moha.gov.vn
Galectin therapeutics director sells shares worth $1.05 million By Investing.com - Investing.com Canada
Galectin Therapeutics (NASDAQ:GALT) Director Sells $105,273.30 in Stock - MarketBeat
Galectin Therapeutics (NASDAQ:GALT) Director Sells $950,820.00 in Stock - MarketBeat
Galectin therapeutics director sells shares worth $1.05 million - Investing.com India
Galectin Therapeutics Insider Sold Shares Worth $1,055,311, According to a Recent SEC Filing - marketscreener.com
Dir Shlevin Sells 175,790 ($1.1M) Of Galectin Therapeutics Inc [GALT] - TradingView — Track All Markets
There is no way Galectin Therapeutics Inc (GALT) can keep these numbers up - Setenews
Galectin Therapeutics shareholders elect board members and approve key proposals By Investing.com - Investing.com Nigeria
10x fund sells Galectin Therapeutics (GALT) shares worth $920,855 By Investing.com - Investing.com Australia
10x fund sells Galectin Therapeutics (GALT) shares worth $920,855 - Investing.com
Galectin Therapeutics : Amendment to Statement of Changes in Beneficial Ownership (Form 4/A) - marketscreener.com
Galectin Therapeutics shareholders elect board members and approve key proposals - Investing.com
Galectin Therapeutics (NASDAQ:GALT) Major Shareholder Fund L.P. 10X Sells 30,000 Shares - MarketBeat
Prepare Yourself for Liftoff: Galectin Therapeutics Inc (GALT) - Setenews
How Galectin Therapeutics Inc. (PHPN) stock reacts to Fed tighteningJuly 2025 Volume & Daily Growth Stock Tips - Newser
Is Galectin Therapeutics Inc. (PHPN) stock a contrarian opportunityBear Alert & Safe Capital Growth Stock Tips - Newser
Fund L.P. 10X Sells 120,000 Shares of Galectin Therapeutics (NASDAQ:GALT) Stock - MarketBeat
10x fund sells Galectin therapeutics (GALT) shares worth $851,700 By Investing.com - Investing.com Canada
10x fund sells Galectin therapeutics (GALT) shares worth $851,700 - Investing.com
Will Galectin Therapeutics Inc. (PHPN) stock benefit from commodity supercycleJuly 2025 Rallies & Short-Term High Return Strategies - Newser
Clinical Progress Drives Galectin Shares Up Post-NAVIGATE Data (NASDAQ:GALT) - Seeking Alpha
Is Galectin Therapeutics Inc. (PHPN) stock a buy on weaknessWeekly Trade Review & Community Consensus Stock Picks - Newser
Is Galectin Therapeutics Inc. (PHPN) stock undervalued historicallyQuarterly Risk Review & High Win Rate Trade Alerts - Newser
Will Galectin Therapeutics Inc. (PHPN) stock rise with strong economy2025 Stock Rankings & Growth Oriented Trading Recommendations - Newser
Can Galectin Therapeutics Inc. (PHPN) stock double in coming yearsQuarterly Profit Report & Daily Growth Stock Tips - Newser
Galectin Therapeutics Reveals Promising NAVIGATE Trial Results - TipRanks
Galectin Therapeutics Inc Presents NAVIGATE Trial Results - TradingView — Track All Markets
Will Galectin Therapeutics Inc. (PHPN) stock sustain bullish trend into 2025Quarterly Growth Report & High Accuracy Investment Entry Signals - Newser
Will Galectin Therapeutics Inc. (PHPN) stock beat international competitionJuly 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - Newser
How big funds are accumulating Galectin Therapeutics Inc. (PHPN) stockMarket Activity Report & Weekly Chart Analysis and Guides - Newser
Why Galectin Therapeutics Inc. stock is favored by pension fundsJuly 2025 Review & Free Technical Confirmation Trade Alerts - BỘ NỘI VỤ
Galectin Therapeutics (NASDAQ:GALT) Shares Cross Above 200 Day Moving AverageTime to Sell? - MarketBeat
The growth track for Galectin Therapeutics Inc (GALT) has changed recently - setenews.com
Will Galectin Therapeutics Inc. stock sustain high P E ratiosTrade Volume Summary & Weekly High Potential Alerts - BỘ NỘI VỤ
Galectin Therapeutics Stock: NAVIGATE Data Validates The Fibrosis Thesis (NASDAQ:GALT) - Seeking Alpha
Wealthspire Advisors LLC Buys 81,144 Shares of Galectin Therapeutics Inc. $GALT - MarketBeat
How Galectin Therapeutics Inc. stock reacts to Fed rate cutsDip Buying & Stepwise Trade Execution Plans - newser.com
How Galectin Therapeutics Inc. (PHPN) stock trades pre earnings2025 Support & Resistance & Fast Entry Momentum Trade Alerts - newser.com
Galectin Therapeutics Inc Azioni (GALT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):